In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $3.96 down -2.22% from its previous closing price of $4.05. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 939013 shares were traded. ALLO stock price reached its highest trading level at $4.0600 during the session, while it also had its lowest trading level at $3.9100.
Ratios:
For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.58 and its Current Ratio is at 12.58. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $7.Citigroup initiated its Buy rating on December 08, 2023, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’24 when Parker Geoffrey M. bought 190 shares for $3.60 per share. The transaction valued at 683 led to the insider holds 819,590 shares of the business.
MESSEMER DEBORAH M. sold 18,640 shares of ALLO for $50,317 on Dec 18 ’23. The Director now owns 62,456 shares after completing the transaction at $2.70 per share. On Aug 07 ’23, another insider, Mayo Stephen, who serves as the Director of the company, sold 10,000 shares for $4.29 each. As a result, the insider received 42,855 and left with 25,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 669.60M and an Enterprise Value of 316.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4184.98 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 3.33k whereas that against EBITDA is -1.05.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $6.89, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 4.4788, while the 200-Day Moving Average is calculated to be 3.8375.
Shares Statistics:
For the past three months, ALLO has traded an average of 2.68M shares per day and 1.41M over the past ten days. A total of 169.09M shares are outstanding, with a floating share count of 104.41M. Insiders hold about 38.25% of the company’s shares, while institutions hold 60.83% stake in the company. Shares short for ALLO as of Mar 15, 2024 were 27.75M with a Short Ratio of 10.34, compared to 23.45M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.41% and a Short% of Float of 24.11%.
Earnings Estimates
There are 14 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.41 for the current quarter, with a high estimate of -$0.22 and a low estimate of -$0.64, while EPS last year was -$0.68. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.23 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$0.91 and -$2.1 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$1.54, with 13 analysts recommending between -$0.24 and -$2.2.
